- Home
- News
- Topics
- FDA Week
- Inside CMS
- Inside Drug Pricing
- Health Exchange Alert
- Inside TeleHealth
- About Us
A new staff analysis from the Senate Finance Committee says the Inflation Reduction Act’s price gouging penalty for drug makers that raise the price of Medicare Part D drugs faster than the rate of inflation has saved $3 billion for seniors and taxpayers since January 2023 and has generally slowed the rate at which companies are seeking to hike drug prices.
Inside Health Policy is a subscription-fee-based daily digital news service from Inside Washington Publishers.
Economical site license packages are available to fit any size organization, from a few people at one location to company-wide access. For more information on how you can get greater access to Inside Health Policy for your office, contact Online Customer Service at 703-416-8505 or healthpolicy@iwpnews.com.
© 2002-2025. Inside Washington Publishers | Contact Us